Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 50 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Israel - English - Ministry of Health

inovamed ltd - emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - tenofovir disoproxil as fumarate 245 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - tenovamed inovamed is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv-1 infected adults over 18 years of age. tenovamed inovamed is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk

Israel - English - Ministry of Health

inovamed ltd - esomeprazole as magnesium trihydrate - gastro resistant tablets - esomeprazole as magnesium trihydrate 20 mg - esomeprazole - esomeprazole inovamed tablets are indicated in adults for:gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophageal reflux disease (gerd)in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and:- healing of helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers.patients requiring nsaid therapy- healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.esomeprazole inovamed 20 mg tablets are indicated in adolescents from the age of 12 years forgastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophgeal reflux disease (gerd)in combination with antibiotics in treatment of duodenal ulcer caused by helicobactor pylori

Israel - English - Ministry of Health

inovamed ltd - esomeprazole as magnesium trihydrate - gastro resistant tablets - esomeprazole as magnesium trihydrate 40 mg - esomeprazole - esomeprazole inovamed tablets are indicated in adults for:gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophageal reflux disease (gerd)in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and:- healing of helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers.patients requiring nsaid therapy- healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.esomeprazole inovamed 40 mg tablets are indicated in adolescents from the age of 12 years for;gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis

Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 300 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 150 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 200 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 400 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Australia - English - Department of Health (Therapeutic Goods Administration)

novamed pty ltd - 31846 - gauge, depth, dental implant - this is a hand-held dental instrument used in surgical implant procedures to accurately measure various depths. this device has graduations on the measuring tip denoting specific depths

Australia - English - Department of Health (Therapeutic Goods Administration)

novamed pty ltd - 35870 - resin-composite dental cement - this is a polymer-based material dispensed as a powder or liquid containing polymethyl methacrylate, a filler, a plasticiser or a polymerization initiator, intended for use in the cementation or fixation of restorations and appliance during dental procedures in the mouth.